Diastolic dysfunction is a feature of the antiphospholipid syndrome

Related Experiment Videos

A M Hasnie1, M F Stoddard, C B Gleason

  • 1Department of Medicine, University of Louisville, KY 40202, USA.

Insights

Primary antiphospholipid syndrome (PAPS) is linked to diastolic dysfunction, impacting left ventricular filling. This study reveals significant echocardiographic differences in PAPS patients compared to healthy controls, highlighting impaired cardiac function.

Area of Science:

  • Cardiology
  • Rheumatology
  • Immunology

Background:

  • Antiphospholipid syndrome (APS) is characterized by thrombosis and pregnancy complications, often associated with anticardiolipin antibodies.
  • Cardiac involvement in primary APS (PAPS) typically involves structural and valvular heart disease.
  • Diastolic dysfunction in PAPS remains under-described.

Purpose of the Study:

  • To investigate the prevalence and characteristics of diastolic dysfunction in patients with primary antiphospholipid syndrome (PAPS).
  • To compare left ventricular diastolic function between PAPS patients and healthy controls using echocardiography.

Main Methods:

  • Echocardiographic assessment of 10 PAPS patients (mean age 30 +/- 7 years) and 10 age-, sex-, weight-, and height-matched healthy controls.
  • Measurement of Doppler-derived left ventricular filling parameters, including peak early filling velocity, peak early to peak atrial filling velocity ratio, and deceleration rate.
  • Enzyme-linked immunosorbent assay (ELISA) to confirm high anticardiolipin antibody concentrations (> 80 IgG phospholipid units) in PAPS patients.

Main Results:

  • PAPS patients exhibited significantly impaired diastolic function compared to controls.
  • Key findings include decreased peak early filling velocity (52 +/- 10 vs 67 +/- 12 cm/sec; p < 0.01) and a reduced early to atrial filling velocity ratio (1.03 +/- 0.40 vs 1.52 +/- 0.28; p < 0.005).
  • Patients also showed a lower mean deceleration rate of early filling (338 +/- 75 vs 590 +/- 227 cm/sec2; p < 0.005) and increased atrial contribution to filling.

Conclusions:

  • Diastolic dysfunction is a significant echocardiographic finding in patients with primary antiphospholipid syndrome.
  • These diastolic abnormalities, particularly impaired left ventricular filling, are associated with high anticardiolipin antibody levels in PAPS.
  • Further research is warranted to understand the clinical implications and management of diastolic dysfunction in PAPS.

Related Concept Videos